TY - JOUR
T1 - Patient-clinician communication and patient-centered outcomes among patients with suspected stage I non-small cell lung cancer
T2 - a prospective cohort study
AU - Nugent, Shannon M.
AU - Golden, Sara E.
AU - Sullivan, Donald R.
AU - Thomas, Charles R.
AU - Wisnivesky, Juan
AU - Saha, Somnath
AU - Slatore, Christopher
N1 - Funding Information:
VA Portland Health Care System: Sujata Thakutra, M.P.A: H.A.; Oregon Health & Science University: Charlotte Kubicky, M.D., Ph.D., John Holland, M.D.; Legacy Health System: Andrew Y. Kee, M.D., and Andrew C. Tsen, M.D.; Providence Health & Services: John R. Handy Jr., M.D., Hon. D., and Steven Seung, MD, Ph.D., FACR; PeaceHealth Southwest Washington Medical Center: Michael A. Myers, M.D (deceased), and Dennis L. Febinger, M.D.; Tuality Healthcare: Timur Mitin, M.D., Ph.D., and Srinivas R. Mummadi, M.D., FCCP; Kaiser Permanente: Kelli D. Salter, M.D., Ph.D., David G. Tse, M.D., and Thomas D. Wynne, M.D
Funding Information:
This study is supported by an award from the Radiation Oncology Institute (#ROI2013-915, Radiation Therapy & Patient-Centered Outcomes among Lung Cancer Patients). It was also supported by resources from the VA Portland Health Care System, Portland, Oregon. Dr. Slatore was supported by a VA HSR&D Career Development Award (CDA 09–025) while the current study was ongoing. Drs. Nugent, Sullivan, and Slatore are supported by resources from the VA Portland Health Care System. Dr. Nugent is supported by an American Cancer Society Mentored Research Scholar Grant (MSRG-18–216-CPHPS).
Publisher Copyright:
© 2022, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
PY - 2022/12
Y1 - 2022/12
N2 - Among patients with suspected early-stage non-small cell lung cancer (NSCLC), we sought to evaluate the association of patient-clinician communication (PCC) with patient-centered outcomes (PCOs). We conducted a multicenter, prospective cohort study examining PCOs at five time points, up to 12-months post-treatment. We used generalized estimating equation (GEE) models adjusted for sociodemographic and clinical variables to examine the relationship between PCC (dichotomized as high- or low-quality) and decisional conflict, treatment self-efficacy, and anxiety. The cohort included 165 patients who were 62% male with a mean age of 70.7 ± SD 8.1 years. Adjusted GEE analysis including 810 observations revealed high-quality PCC was associated with no decisional conflict (adjusted odds ratio [aOR] = 0.14, 95% CI = 0.07 to 0.27) and higher self-efficacy (β = −0.26, 95% CI = −0.37 to −0.14). High-quality PCC was not associated with moderately severe anxiety (aOR = 0.68, 95% CI = 0.41 to 1.09), though was associated with decreased anxiety scores (β = −3.91, 95% CI = −6.48 to −1.35). Among individuals with suspected early-stage NSCLC, high-quality PCC is associated with less decisional conflict and higher self-efficacy; the relationship with anxiety is unclear. Clinicians should prioritize enhanced treatment-related communication at critical and vulnerable periods in the cancer care trajectory to improve PCOs.
AB - Among patients with suspected early-stage non-small cell lung cancer (NSCLC), we sought to evaluate the association of patient-clinician communication (PCC) with patient-centered outcomes (PCOs). We conducted a multicenter, prospective cohort study examining PCOs at five time points, up to 12-months post-treatment. We used generalized estimating equation (GEE) models adjusted for sociodemographic and clinical variables to examine the relationship between PCC (dichotomized as high- or low-quality) and decisional conflict, treatment self-efficacy, and anxiety. The cohort included 165 patients who were 62% male with a mean age of 70.7 ± SD 8.1 years. Adjusted GEE analysis including 810 observations revealed high-quality PCC was associated with no decisional conflict (adjusted odds ratio [aOR] = 0.14, 95% CI = 0.07 to 0.27) and higher self-efficacy (β = −0.26, 95% CI = −0.37 to −0.14). High-quality PCC was not associated with moderately severe anxiety (aOR = 0.68, 95% CI = 0.41 to 1.09), though was associated with decreased anxiety scores (β = −3.91, 95% CI = −6.48 to −1.35). Among individuals with suspected early-stage NSCLC, high-quality PCC is associated with less decisional conflict and higher self-efficacy; the relationship with anxiety is unclear. Clinicians should prioritize enhanced treatment-related communication at critical and vulnerable periods in the cancer care trajectory to improve PCOs.
KW - Early-stage lung cancer
KW - Patient-centered outcomes
KW - Patient-clinician communication
KW - Prospective cohort
UR - http://www.scopus.com/inward/record.url?scp=85138933910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138933910&partnerID=8YFLogxK
U2 - 10.1007/s12032-022-01776-y
DO - 10.1007/s12032-022-01776-y
M3 - Article
C2 - 36175802
AN - SCOPUS:85138933910
SN - 1357-0560
VL - 39
JO - Medical Oncology
JF - Medical Oncology
IS - 12
M1 - 203
ER -